Consultant Pharmacist at Doncaster Royal Infirmary
Role of dual and triple fixed-dose combination inhalers in the treatment of chronic obstructive pulmonary diseaseSubscription
A review of the current evidence, including the safety and efficacy of dual and triple-combination inhalers for the treatment of stable COPD, and their place in therapy.
The UK is experiencing an explosion of new drugs and inhaler devices being licensed for people with respiratory disease, increasing the complexity of prescribing for people with asthma or chronic obstructive pulmonary disease (COPD). The management of how these new products are introduced into clinical practice is important because they may vary in type of inhaler device and licensing. One product is DuoRespSpiromax, a cheaper “branded generic” of Symbicort Turbohaler, both containing
Asthma: long-term managementSubscription
Asthma management is based on a stepwise approach that should see medicines added or stopped based on patient symptoms.
Asthma: pathophysiology, causes and diagnosisSubscription
Our concerns with Relvar ElliptaSubscription
Primum non nocereSubscription